This research study is being carried out to better understand the potential anti-inflammatory effects of an investigational study drug on reducing the risk of severe asthma attacks. The study will be virtual, there are no scheduled in-person clinic visits required.
You may qualify for this study if you:
- Are 12 years of age or older
- Have been diagnosed with asthma and are treated with one of the following: SABA only or low-dose ICS+SABA or leukotriene modifier+SABA
- Use a rescue inhaler (albuterol) OR a rescue inhaler plus either a steroid inhaler like Flovent (fluticasone) or a medicine like Singulair (montelukast)
This study may provide compensation for your time and travel.Sign Up Today